7:45-8:15am
Registration Open
8:15-9:15
PRODUCT THEATRE I - Non-CME
Breakfast Session
Management of CKD and Hyperkalemia
Souhiela Fawaz, BS Pharm, PhD
Warren Fegenbush, PharmD, BCPS
Supported by: AstraZeneca
9:30am
Introduction to the 28th Annual Symposium: Heart Failure in 2022
Barry Greenberg, MD
SESSION I - Update on Risk Factors and Prevention
Michael Wilkinson, MD (Moderator)
9:40-9:55
FEATURED LECTURE I
Exercise for CV Disease Prevention
Michael Wilkinson, MD
9:55-10:10
Complementary and Alternative Medicines for Treating CV Disease
Sheryl Chow, Pharm D
10:10-10:25
Strategies for Managing Hypertension to Prevent CV and Renal Disease
Christian Mende, MD
10:25-10:40
New Therapies for Hyperlipidemia
Michael Wilkinson, MD
10:40-10:55
Treating Diabetes to Prevent CV Disease
Jia Shen, MD
10:55-11:20
Panel Discussion / Audience Q & A
Reducing Risk of CV and CK Disease
Jia Shen, MD (Moderator)
Drs. Mende, Wilkinson, Chow and
Alexandra Salcedo, RDN, CDCES (Panelists)
11:20-11:40
FEATURED LECTURE II
Pulmonary Arterial Hypertension: Diagnosis and Management
Nick Kim, MD
11:50-12:50
PRODUCT THEATRE II - Non-CME
Lunch Session
Redefining the Treatment Landscape of Symptomatic NYHA Class II-III Obstructive HCM With CAMZYOS™, the First and Only FDA-Approved Cardiac Myosin Inhibitor
Florian Rader, MD Bio
Supported by: Bristol Meyers Squibb
1:00-1:15
Visit Exhibit Hall
Session II - HFpEF, Amyloid and Hypertrophic Cardiomyopathy
Marcus Anthony (Tony) Urey, MD (Moderator)
1:15-1:35
FEATURED LECTURE III
Recognizing and Treating Amyloid
Marcus Anthony (Tony) Urey, MD
1:35-1:55
Emerging Concepts of Understanding and Treating HFpEF
Barry Greenberg, MD
1:55-2:15
Managing Patients with Hypertrophic Cardiomyopathy (HCM) in 2022
Jorge Silva Enciso, MD
2:15-2:35
Genetic Testing for Diseases Causing Cardiomyopathy
Kimberly Hong, MD
2:35-2:55
Case Presentation / Audience Q & A
Marcus Anthony (Tony) Urey, MD (Presenter)
Drs. Greenberg, Silva Enciso and Hong (Panelists)
2:55-3:15
Coffee Break/Visit Exhibit Hall
Session III - Managing Atrial Fibrillation and Prevention of Sudden Death
Ulrika Birgersdotter-Green, MD (Moderator)
3:15-3:30
Stroke Prevention in Patients with Atrial Fibrillation; Drugs and Devices
Jonathan Hsu, MD
3:30-3:45
Predictors of Sudden Cardiac Death
Gordon Ho, MD
3:45-4:00
Wearable Devices for Detecting and Treating Arrhythmias
David Krummen, MD
4:00-4:15
ICDs for Preventing Sudden Cardiac Death
Ulrika Birgersdotter Green, MD
4:15-4:35
Case Presentation / Audience Q & A
Ulrika Birgersdotter-Green, MD (Moderator)
Drs. Hsu, Ho and Krummen (Panelists)
4:35
Adjourn Day 1
6:40am
Registration Opens
7:00-8:00
PRODUCT THEATRE III - Non-CME
Breakfast Session
Treatment considerations for patients with HFrEF and select updates from the 2022 HF Guideline
Warren Wexelman, MD
supported by: Merck
8:00-8:15
Visit Exhibit Hall
8:15
Welcome to Day 2 / Highlights of Day 1
Barry Greenberg, MD
Session IV - Prevention of CV Events and Assessing Patients with Heart Failure
Barry Greenberg, MD (Moderator)
8:20-8:35
DOACs to Prevent CV Disease
Dan Blanchard, MD
8:35-8:50
Devices for Detecting and Preventing Worsening HF
Hao (Howie Tran), MD
8:50-9:05
Assessing Kidney Function in Patients with Heart Failure:
Implications for Patient Management
Nick Wettersten, MD
9:05-9:20
Biomarkers to Assess Presence of HF, Risk of Events and Response to Treatment
Lori Daniels, MD
9:20-9:40
FEATURED LECTURE IV
Acute and Long Term Effects of COVID on the Heart
Pam Taub, MD
9:40-10:00
Panel Discussion / Audience Q/A
Barry Greenberg, MD (Moderator)
Drs. Tran, Wettersten, Daniels, Blanchard and Taub (Panelists)
10:00-10:20
Coffee Break / Visit Exhibit Hall
10:20-11:20
PRODUCT THEATRE IV - Non-CME
Improved Management Strategies for Patients with Heart Failure and Coronary Artery Disease - The Who, How and Why
Sponsored by Abiomed
10:20
Introduction: Defining the Problem
Barry Greenberg, MD
10:25-10:40
Recognizing CAD in Heart Failure Patients - The Who
Nancy Albert, RN, PhD
10:40-10:55
Revascularization Impact on HF Symptoms with Reduced EF: Insights from Restore-EF & Protect III - The How
Mitul Patel, MD
10:55-11:05
Achieving GDMT for Ischemic Cardiomyopathy
Gregg Fonarow, MD
11:05-11:20
Ischemic HF and PCI: Emerging Evidence in Patients with Systolic Dysfunction (PROTECT IV) - The Why
Ehtisham Mahmud, MD
Session V - Meeting the Challenges in Worsening Heart Failure with Reduced Ejection Fraction: Opportunities to Improve Clinical Outcomes
LUNCH SESSION
Supported by an independent educational grant from Cytokinetics Incorporated
11:30
Introduction
Barry Greenberg, MD
11:35-11:55
Worsening Heart Failure in HFrEF: Clinical Course and Challenges in Patient Management
Gregg Fonarow, MD
11:55-12:15
New and Emerging Therapies for WHF in HFrEF: Exploring the Evidence with Vericiguat and Omecamtiv Mecarbil
John Teerlink, MD
12:15-12:35
Case Presentation
Improving Outcomes in Patients with HFrEF and WHF
Kimberly Hong, MD (Presenter)
Gregg Fonarow, MD; John Teerlink, MD; Marcus Anthony (Tony) Urey, MD; Trina Huynh, Pharm D (Panelists)
12:35-12:45
Audience Q & A
Barry Greenberg, MD (Moderator)
Drs. Teerlink, Fonarow, Hong, Urey and Huynh (Panelists)
12:45-1:00
Coffee Break / Visit Exhibit Hall
1:00-1:30
8th Annual Stanley Lloyd, MD Lecture
Recognizing and Correcting Inequities in Health Care
Cheryl Anderson, MD
1:30
Audience Q & A
Session VI - Advanced Therapies
Eric Adler, MD (Moderator)
1:40-1:55
Recognizing Stage D Heart Failure
Kimberly Hong, MD
1:55-2:15
FEATURED LECTURE V
Advances in Cardiac Transplantation: What Can Patients Expect?
Victor Pretorius, MBChB
2:15-2:30
Role of Left Ventricular Assist Devices in Management of Stage D HF
Eric Adler, MD
2:30-2:45
Gene and Cell Therapies - Closer and Closer to Prime Time
Barry Greenberg, MD
2:45-3:00
Panel Discussion
Eric Adler, MD (Moderator)
Drs. Hong, Pretorius, Urey, Greenberg and Holly Anguiano, LCSW (Discussants)
3:00-3:10
Coffee Break / Visit Exhibit Hall
Session VII - Optimizing the Medical Management of Patients with Heart Failure
Barry Greenberg, MD (Moderator)
3:10-3:25
What’s New in ’22 - Insights into the 2022 ACC/AHA/HFSA Guidelines for HF
Clyde Yancy, MD
3:25-3:40
Expanding Indications for ARNIs in Treating Heart Failure
Barry Greenberg, MD
3:40-3:55
SGLT2 Inhibitors for Treating HFrEF, HFpEF and Everything In Between
Gregg Fonarow, MD
3:55-4:10
Other Medications: Role of Ivabradine, Vericiguat, Hyd-ISDN, Digoxin
Clyde Yancy, MD
4:10-4:25
Mineralocorticoid Receptor Antagonists to Prevent CV Disease and Treat HF
Nick Wettersten, MD
4:25-4:45
FEATURED PANEL
Putting It All Together - How To Implement Disease Modifying Therapies
(Case Presentation, Panel Discussion, Audience Q & A)
Barry Greenberg, MD (Moderator)
Drs. Yancy, Fonarow and Wettersten, Trina Huynh Pharm D, Julia McCain, PA (Panelists)
4:45
Adjourn Until the 29th Annual San Diego Heart Failure Symposium